Business

Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma

Wall Street turned its focus to a handful of newer treatments in different disease areas in 2023, including weight loss medications and a new Alzheimer’s drug.

Previous post De Beers says its push to tackle the glut in the diamond market is now starting to work
Next post Mortgage demand slips despite another drop in interest rates

More Stories